Elevation Oncology Ownership | Who Owns Elevation Oncology?


OverviewForecastFinancialsChart

Elevation Oncology Ownership Summary


Elevation Oncology is owned by 11.46% institutional investors, 0.35% insiders, and 88.19% retail investors. Frazier life sciences management is the largest institutional shareholder, holding 10.14% of ELEV shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.76% of its assets in Elevation Oncology shares.

ELEV Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockElevation Oncology11.46%0.35%88.19%
SectorHealthcare Stocks 279.19%10.58%-189.76%
IndustryBiotech Stocks 63.97%10.68%25.35%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Frazier life sciences management5.99M10.14%$1.55M
Tang capital management4.76M8.05%$2.68M
Blackrock funding, inc. /de3.16M5.35%$1.78M
Aisling capital management lp2.83M4.80%$1.59M
Vanguard group2.61M4.42%$1.47M
Blackrock2.49M4.22%$6.72M
Goldman sachs group1.65M2.79%$929.26K
Renaissance1.60M2.71%$902.02K
Morgan stanley1.27M2.16%$3.44M
Geode capital management1.16M1.96%$651.36K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Aisling capital management lp2.83M0.56%$1.59M
Tang capital management4.76M0.18%$2.68M
Sphera funds management1.02M0.10%$573.04K
Frazier life sciences management5.99M0.07%$1.55M
Artal group1.01M0.07%$2.74M
Ikarian capital690.05K0.02%$178.79K
Palumbo wealth management69.11K0.01%$38.88K
Velan capital investment management lp45.00K0.01%$11.66K
Two sigma securities62.38K0.00%$35.09K
Boothbay fund management183.45K0.00%$103.21K

Top Buyers

HolderShares% AssetsChange
Blackrock2.49M0.00%2.32M
Morgan stanley1.27M0.00%1.25M
Blackrock funding, inc. /de3.16M-258.01K
Deutsche bank ag\188.77K-159.75K
Jpmorgan chase180.38K-119.04K

Top Sellers

HolderShares% AssetsChange
Logos global management lp---3.85M
Farallon capital management---3.53M
Bvf inc/il---2.97M
Balyasny asset management---2.48M
Venbio partners---2.43M

New Positions

HolderShares% AssetsChangeValue
Wellington management group llp116.07K0.00%116.07K$313.38K
Two sigma securities62.38K0.00%62.38K$35.09K
Susquehanna group, llp37.92K-37.92K$21.34K
Vanguard personalized indexing management20.21K0.00%20.21K$11.37K
Voya investment management18.48K0.00%18.48K$49.89K

Sold Out

HolderChange
Capital performance advisors llp-11.00
Nisa investment advisors-1.16K
Macquarie group-1.27K
Amalgamated bank-1.80K
Mercer global advisors inc /adv-10.03K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20254-94.44%6,773,820-83.05%110.25%--100.00%1-92.31%
Dec 31, 2024712.90%33,979,478-26.03%570.95%39-13-23.53%
Sep 30, 202469-14.81%45,936,801-11.86%771.00%39-25.00%17-19.05%
Jun 30, 20248126.56%52,117,51618.46%881.02%521.96%21133.33%
Mar 31, 202464106.45%43,997,46970.21%922.50%51628.57%928.57%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.64M2.76%-
iShares Russell 2000 ETF1.29M2.19%633.00
Aesculape SRI IC755.00K1.27%-
Vanguard Institutional Extnd Mkt Idx Tr608.57K1.03%-
Fidelity Small Cap Index552.58K0.93%16.13K
iShares Russell 2000 Growth ETF461.96K0.78%-
Vanguard US Momentum Factor ETF430.42K0.73%430.42K
State St Russell Sm/Mid Cp® Indx NL Cl C300.71K0.51%-
State St Russell Sm/Mid Cp® Indx SL Cl I300.71K0.51%-
Fidelity Extended Market Index287.51K0.49%3.50K

Recent Insider Transactions


DateNameRoleActivityValue
May 25, 2022venBio Global Strategic Fund III, L.P.-Sell$2.90M
May 25, 2022Royston Aaron Sell$2.90M
Jun 29, 2021Qiming U.S. Healthcare Fund II, L.P.-Buy$5.00M
Jun 29, 2021Aisling Capital IV, LP-Buy$3.00M
Jun 29, 2021venBio Global Strategic Fund III, L.P.-Buy$10.00M

Insider Transactions Trends


DateBuySell
2025 Q1--
2024 Q4--
2024 Q3--
2024 Q2--
2024 Q1--

ELEV Ownership FAQ


Who Owns Elevation Oncology?

Elevation Oncology shareholders are primarily institutional investors at 11.46%, followed by 0.35% insiders and 88.19% retail investors. The average institutional ownership in Elevation Oncology's industry, Biotech Stocks , is 63.97%, which Elevation Oncology falls below.

Who owns the most shares of Elevation Oncology?

Elevation Oncology’s largest shareholders are Frazier life sciences management (5.99M shares, 10.14%), Tang capital management (4.76M shares, 8.05%), and Blackrock funding, inc. /de (3.16M shares, 5.35%). Together, they hold 23.54% of Elevation Oncology’s total shares outstanding.

Does Blackrock own Elevation Oncology?

Yes, BlackRock owns 4.22% of Elevation Oncology, totaling 2.49M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 6.72M$. In the last quarter, BlackRock increased its holdings by 2.32M shares, a 1348.65% change.

Who is Elevation Oncology’s biggest shareholder by percentage of total assets invested?

Aisling capital management lp is Elevation Oncology’s biggest shareholder by percentage of total assets invested, with 0.56% of its assets in 2.83M Elevation Oncology shares, valued at 1.59M$.

Who is the top mutual fund holder of Elevation Oncology shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Elevation Oncology shares, with 2.76% of its total shares outstanding invested in 1.64M Elevation Oncology shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools